Your session is about to expire
← Back to Search
Portion Size for Shift Work Sleep Disorder
N/A
Recruiting
Led By Faris M Zuraikat, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 20-55 years of age
Metabolically healthy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24-hours intake period
Awards & highlights
Study Summary
This trial will look at whether different eating behaviors during the day or night impact feelings of hunger and fullness in people who work night shifts.
Who is the study for?
This trial is for day or night shift workers aged 20-55, with a BMI of 19-35, living in the NYC area. They must be metabolically healthy and weight stable for the past three months. It's not open to pregnant women, smokers, those with certain health conditions like cardiovascular disease or diabetes, or anyone on a recent diet program.Check my eligibility
What is being tested?
The study is looking at how portion size affects hunger and fullness in day versus night shift workers to understand their higher obesity risk. Participants' eating behaviors will be compared based on their work shifts.See study design
What are the potential side effects?
Since this trial involves monitoring eating behavior rather than testing a drug or medical treatment, there are no direct side effects associated with participating in this study.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 20 and 55 years old.
Select...
My metabolism is healthy.
Select...
I work at least 8 hours a day for 3 or more days each week.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24-hours intake period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24-hours intake period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Energy density consumed
Energy intake
Food intake
Secondary outcome measures
Appetite-regulating hormones
Hunger and fullness
Trial Design
2Treatment groups
Active Control
Group I: Day workerActive Control1 Intervention
Men and women who work only day shift for at least 3 consecutive days of the week
Group II: Night workerActive Control1 Intervention
Men and women who work only night shift for at least 3 consecutive days of the week
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,426 Previous Clinical Trials
2,473,708 Total Patients Enrolled
1 Trials studying Eating Disorders
202 Patients Enrolled for Eating Disorders
Faris M Zuraikat, PhDPrincipal InvestigatorColumbia University
Marie-Pierre St-Onge, PhDPrincipal Investigator - Columbia University
Columbia University
8 Previous Clinical Trials
341 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I work in shifts that change periodically.I have type 2 diabetes.I have a diagnosed psychiatric or sleep disorder.I am between 20 and 55 years old.You live in the New York City area.I have not joined any diet or weight loss program in the last 3 months.You typically sleep for more than 6 hours every night.You have allergies or intolerances to certain foods.I have obstructive sleep apnea.I am unwilling or dislike eating certain test foods.Traveling across different time zones.My metabolism is healthy.I have high blood pressure.Your weight has stayed the same for the past 3 months.I work at least 8 hours a day for 3 or more days each week.I have a heart condition.I am currently pregnant or have given birth within the last year.You are a smoker.You have a history of using drugs or drinking too much alcohol.Your body mass index (BMI) is between 19 and 35.
Research Study Groups:
This trial has the following groups:- Group 1: Day worker
- Group 2: Night worker
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger